-
Charter of Relationship Principles for Nishnawbe Aski Nation Territory
A Charter between the Government of Canada, the Government of Ontario, and the Nishnawbe Aski Nation (NAN) on behalf of the First Nations in NAN Territory. -
Health Product InfoWatch: September 2021
The Health Product InfoWatch is a monthly publication intended primarily for healthcare professionals. It provides clinically relevant safety information on pharmaceuticals,... -
Registration Decision RD2020-09, Bacillus amyloliquefaciens strain PTA-4838...
This decision is consistent with the Proposed Registration Decision PRD2020-07, Bacillus amyloliquefaciens strain PTA-4838 and AVEO EZ Nematicide, whichcontains a detailed... -
Acoustics: Chronic noise exposure in the spontaneously hypertensive rat
Health Canada conducts research to assess the potential health risks from noise as part of its role in administering the Radiation Emitting Devices Act, which governs the... -
Patent Register Data
The Patent Register is an alphabetical listing of medicinal ingredients and their associated patents, the patent expiry dates and other related information established in... -
Consumer Product Enforcement Summary Report: Hazardous Products (Charcoal)...
The purpose of this Cyclical Enforcement (CE) project was to verify compliance of charcoal products which are subject to the Hazardous Products (Charcoal) Regulations. -
Opioid Pain Medications
Opioid pain medications include a broad range of drugs, such as morphine, codeine and oxycodone. When used as directed, opioid pain medications are effective and the side... -
Guidance Document - Non-prescription Oral Adult Antitussive Cough and Cold...
This labelling standard describes the requirements necessary to receive market authorization (a Drug Identification Number (DIN)) for non-prescription oral antitussive products... -
Registration Decision RD2020-16, Broflanilide, Cimegra, Teraxxa and Teraxxa F4
This decision is consistent with the Proposed Registration Decision, PRD2020-06, Broflanilide, Cimegra, Teraxxa and Teraxxa F4, which contains a detailed evaluation of the... -
Draft technical document guidelines for Canadian drinking water quality -...
There are limited data on the toxicological effects of antimony in humans. The majority of the human data in the literature come from the reported side effects observed during... -
Respiratory health
Health Canada approved one new generic drug for respiratory health. -
Summary Safety Review - Levetiracetam and Methotrexate - Assessing the...
Health Canada carried out a safety review after learning that the European Medicines Agency was looking into a potential interaction between levetiracetam and methotrexate. The... -
Regulations amending the food and drug regulations (1024 - clinical trials)
Food and Drug Regulations-Amendment (Schedule No.1024) Clinical Trial Framework -
Ensuring predictability for COVID-19 clinical trials and proposal for...
The purpose of this notice is to advise stakeholders that Health Canada is proposing to: maintain the flexibilities and regulatory oversight provided by the Interim order... -
Notice - Draft Guidance Document: Administrative Processing of Drug...
The draft guidance document clarifies the requirements for eligible drug submissions and applications under the administrative pathway. These submissions and applications do not... -
Power lines and electrical products: Extremely low frequency electric and...
Power lines and electrical products emit extremely low frequency electric and magnetic fields (EMF). Learn about the safety of power lines and electrical products. -
Guidance on amendments to the Food and Drug Regulations for drugs for use in...
As a consequence of the review, authorization and oversight of COVID-19 drugs under the Regulations, manufacturers may benefit from intellectual property protections that are... -
Directory of Nutrition Facts Table Formats for Edible Cannabis
Displays edible cannabis nutritional facts table formats and key presentation requirements.